This year has seen a double dose of optimism in the field of HIV prevention. First, on 20 June 2024, came the results of the Purpose-1 trial in South Africa and Uganda.1 This randomised controlled ...
PinkNews on MSN2h
Tory says Section 28 opponents wanted schools to teach ‘the behaviour that caused Aids’Conservative peer Baroness Nicholson has claimed those who opposed Section 28, the legislation which banned the ‘promotion’ ...
Gilead Sciences’s decision to distribute HIV prevention drug lenacapavir made the news this month when they signed ...
Daily Maverick on MSN2h
Efficacy of six-monthly HIV prevention jab confirmed in second major studyIn June, we heard what could be this year’s biggest HIV breakthrough: a twice-yearly injection can prevent HIV infection. A ...
Babies born to mothers with HIV should receive HIV drugs within six hours after birth to prevent mother-to-child transmission ...
Within two to four weeks after HIV infection, many, but not all, people develop flu-like symptoms, including fever, swollen ...
In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...
Following the passing of popular Benga songstress Princess Jully this past weekend, fans and Kenyans have come out to honour ...
This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...
A photograph allegedly showing Diana, Princess of Wales, in 1991 shaking hands with a man diagnosed with HIV/AIDS — at a time ...
The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...
The measure waives the need for a primary care physician’s prescription for HIV medications like PrEP and Doxy PEP.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback